Fang Hua

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Nature communications

Signal transduction and targeted therapy

Science translational medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Shuang Shang, Chen Yang, Fei Chen, Ren-Shen Xiang, Huan Zhang, Shu-Yuan Dai, Jing Liu, Xiao-Xi Lv, Cheng Zhang, Xiao-Tong Liu, Qi Zhang, Shuai-Bing Lu, Jia-Wei Song, Jiao-Jiao Yu, Ji-Chao Zhou, Xiao-Wei Zhang, Bing Cui, Ping-Ping Li, Sheng-Tao Zhu, Hai-Zeng Zhang, Fang Hua
ID1 expressing macrophages support cancer cell stemness and limit CD8 + T cell infiltration in colorectal cancer. Nature communications 14 (1) (2023)
Cheng Zhang, Jiao-Jiao Yu, Chen Yang, Zhen-Long Yuan, Hui Zeng, Jun-Jian Wang, Shuang Shang, Xiao-Xi Lv, Xiao-Tong Liu, Jing Liu, Qi Xue, Bing Cui, Feng-Wei Tan, Fang Hua
Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. Science translational medicine 15 (726) (2023)
Shuang Shang, Jing Liu, Fang Hua
Protein acylation: mechanisms, biological functions and therapeutic targets. Signal transduction and targeted therapy 7 (1) (2022)
Shuang Shang, Jing Liu, Fang Hua
Protein acylation: mechanisms, biological functions and therapeutic targets. Signal transduction and targeted therapy 7 (1) (2022)
Shuang Shang, Yu-Wei Yang, Fei Chen, Liang Yu, Shuo-Hao Shen, Ke Li, Bing Cui, Xiao-Xi Lv, Cheng Zhang, Chen Yang, Jing Liu, Jiao-Jiao Yu, Xiao-Wei Zhang, Ping-Ping Li, Sheng-Tao Zhu, Hai-Zeng Zhang, Fang Hua
TRIB3 reduces CD8 + T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer. Science translational medicine 14 (626) (2022)
Shuang Shang, Jing Liu, Fang Hua
Protein acylation: mechanisms, biological functions and therapeutic targets. Signal transduction and targeted therapy 7 (1) (2022)
Cheng Zhang, Jiao-Jiao Yu, Chen Yang, Shuang Shang, Xiao-Xi Lv, Bing Cui, Fang Hua
Crosstalk between ferroptosis and stress-Implications in cancer therapeutic responses. Cancer innovation 1 (1) (2022)
Shuang Shang, Jing Liu, Fang Hua
Protein acylation: mechanisms, biological functions and therapeutic targets. Signal transduction and targeted therapy 7 (1) (2022)
Ke Li, Ting-Ting Zhang, Chen-Xi Zhao, Feng Wang, Bing Cui, Zhao-Na Yang, Xiao-Xi Lv, Zaiwuli Yeerjiang, Yu-Fen Yuan, Jin-Mei Yu, Zhen-He Wang, Xiao-Wei Zhang, Jiao-Jiao Yu, Shan-Shan Liu, Shuang Shang, Bo Huang, Fang Hua, Zhuo-Wei Hu
Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability. Science translational medicine 13 (586) (2021)
Wan Du, Fang Hua, Xiong Li, Jian Zhang, Shasha Li, Weichao Wang, Jiajia Zhou, Weimin Wang, Peng Liao, Yijian Yan, Gaopeng Li, Shuang Wei, Sara Grove, Linda Vatan, Witold Zgodziński, Marek Majewski, Grzegorz Wallner, Haoyan Chen, Ilona Kryczek, Jing-Yuan Fang, Weiping Zou
Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation. Cancer discovery 11 (7) (2021)
Jiao-Jiao Yu, Dan-Dan Zhou, Xiao-Xiao Yang, Bing Cui, Feng-Wei Tan, Junjian Wang, Ke Li, Shuang Shang, Cheng Zhang, Xiao-Xi Lv, Xiao-Wei Zhang, Shan-Shan Liu, Jin-Mei Yu, Feng Wang, Bo Huang, Fang Hua, Zhuo-Wei Hu
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target. Nature communications 11 (1) (2020)
Ke Li, Feng Wang, Zhao-Na Yang, Ting-Ting Zhang, Yu-Fen Yuan, Chen-Xi Zhao, Zaiwuli Yeerjiang, Bing Cui, Fang Hua, Xiao-Xi Lv, Xiao-Wei Zhang, Jiao-Jiao Yu, Shan-Shan Liu, Jin-Mei Yu, Shuang Shang, Yang Xiao, Zhuo-Wei Hu
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation. Nature communications 11 (1) (2020)
Jin-Mei Yu, Wei Sun, Zhen-He Wang, Xiao Liang, Fang Hua, Ke Li, Xiao-Xi Lv, Xiao-Wei Zhang, Yu-Ying Liu, Jiao-Jiao Yu, Shan-Shan Liu, Shuang Shang, Feng Wang, Zhao-Na Yang, Chen-Xi Zhao, Xue-Ying Hou, Ping-Ping Li, Bo Huang, Bing Cui, Zhuo-Wei Hu
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription. Nature communications 10 (1) (2019)